It has been shown that overexpression of Hsp90 in cancer tissues, particularly in hepatocellular carcinoma, is associated with a poor prognosis and poor therapeutic outcomes [67,68]. This evidence concerns the gene HSP90AA1 and hepatocellular carcinoma.